My Companies
Notification
Account
Board recommended raising up to USD 50 million through FCCBs in one or more private-placement tranches, subject to regulatory and statutory approvals. This revives the delayed FCCB fundraising plan and supports Kellton's product development and growth ambitions, but introduces potential equity dilution. Conversion terms, pricing, timing, allocation of proceeds and the eventual debt-equity mix remain undisclosed; reappointments and AGM scheduling are routine.
Kellton Selected To Build AI Claims Platform For U.S. Healthcare Company
Kellton Receives ADB Excellence Award, Targets $5 Million Strategic Account